Day: August 2, 2020

Raphael Mechoulam – 9th September

Dr Raphael Mechoulam: the chemist responsible for isolating Tetrahydrocannabinol addressed attendees in the keynote speech at the International Cannabis Business Conference in Berlin to explain his cannabis research which unleashed the secrets of the cannabis plant.

Best known for his discovery of tetrahydrocannabinol (THC), one of the 113 known cannabinoids found in the cannabis plant. Mechoulam jumpstarted the medical revolution which has transformed the debate around cannabis and the lives of so many people.

Dr Dani Gordon – Speaking Soon


Dr Dani is a double board certified medical doctor, integrative medicine physician and world leading expert in CBD, cannabis medicine,  brain wellness & stress resilience.

She was one of the youngest physicians to become American board certified in Integrative Medicine (the newest US physician subspecialty), co-founded the UK Medical Cannabis Clinicians’s Society (MCCS), trained the UK’s first cannabis medicine specialists and helped set up the UK’s first cannabis medicine centres.

She has lectured at Imperial College, King’s College, and UCL on medical cannabis. She also developed the first medical cannabis training program for physicians in the UK and is a consultant for clinical research in cannabinoid medicine working with top researchers around the world.

She is a published researcher and her book THE CBD BIBLE: Cannabis and the Wellness Revolution That Will Change Your Life. Publication is scheduled for publication on June 11th 2020.

She has studied mindbody medicine at Harvard, yoga and meditation extensively throughout India and southeast Asia with traditional teachers, QEEG brain scanning and EEG neurofeedback brainwave training with the top leaders in North America and was the founder of a neurofeedback centre specializing in burnout, peak mental performance and stress resilience.

She is regularly featured in the Sunday Times, The Guardian, Telegraph, Fast Company, Forbes, BBC radio and has been featured on the BBC and Channel 4 TV.

The future of Medical Cannabis in UK – Dr Benjamin Viaris de Lesegno

Co-founder and CMO of Cellen. Cellen is a HealthTech company on a mission to improve the health and wellbeing of people living with chronic conditions.
I have been an NHS consultant since 2016. I trained in France where I have been Chef de Clinique – Assistant universitaire des hôpitaux de Paris. I practice Obstetrics and Gynaecology and trained in Maternal and Fetal Medicine. I also have an MSc in Genetics. I participate in research and teaching in my daily life.
I have been on several humanitarians missions and have worked in places as different as the slums of India, Syrian refugee camps at the beginning of the war, the Jungle of Calais with migrant population from Africa, the Middle East or South east Asia.
When I am not delivering babies, doing researching on fetal genetic diseases, teaching to medical students or caring for patients in a refugee camp, I actively participate in the Health Tech scenes in France and in the UK. I am the founder and organiser of the first Startup Weekend Health in France and in the UK. I am the Techstars mentor in Health Tech for the London accelerator, belong to the CCIO network, am the Health Tech Chapter Leader for the French Tech, etc.

Benjamin had an open and frank discussion with parents of Medcan about the future of medical cannabis in the UK and access on the NHS.

Endocannabinoid system – Professor Mike Barnes – 18th August

Professor Mike Barnes will be holding a webinar with MED CAN on prescription – Parents/Carers support group talking about the endocannabinoid system, 18th Aug 7pm.

Professor Barnes MD FRCP is a leading clinical neurologist and consultant in rehabilitation medicine. He is the Honorary Professor of Neurological Rehabilitation at the University of Newcastle, Founder and President of the World Federation of Neurological Rehabilitation and past President of the British Society of Rehabilitation Medicine and was elected to the membership of the European Academy of Rehabilitation Medicine. He has also served as the chief executive of several NHS organisations and is considered to be a leading world authority in neurological rehabilitation.

As the first UK doctor to successfully negotiate a prescription for medical cannabis from the government (in the case of Alfie Dingley), Professor Barnes is recognised as a powerful and influential voice in medical cannabis policy in Europe.

Mike also the Clinical Director of the Medical Cannabis Clinics, London.

Dr Callie Seaman


Dr Callie Seaman is a veteran of the hydroponic industry. First studying for a degree in Biomedical Sciences at Sheffield Hallam University, during which she worked at GlaxoSmithKline,  she went on to complete a PhD on The Investigating nutrient solution for hydroponic growth of plants. During her PhD she became a director by helped to set up the hydroponic nutrient manufacturing company Aqualabs Ltd, creating brands such as Shogun and Silver bullet. In 2018 she continued at Sheffield Hallam with a Post Doctorate role monitoring metal uptake into Soya crops. For the past 20 years and throughout all of this time, Callie has been passionate about the medicinal properties of cannabis and decided to join the team at Hempire Ltd in October 2018, a Licenced medicinal cannabis cultivator based in the UK.

Dr Callie gave a really informative presentation, she covered the plant, phytocannabinoids, extraction processes and differences between them, lab testing and what they test for and what parents should be looking for in products. She then spoke about her own use with cannabis in treating her epilepsy.

To see this webinar, head over to our facebook group and the webinar is recorded.

Dr Bonni Goldstein

A native of New Jersey, Dr. Bonni Goldstein received her undergraduate education at Rutgers College.

She pursued her medical degree at Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey. Her post-doctoral education included internship and residency at Childrens Hospital Los Angeles.

Dr. Goldstein also served as Chief Resident at Childrens Hospital Los Angeles. She was a Clinical Instructor in Pediatrics at USC School of Medicine in Los Angeles, Emergency Transport Attending Physician at Childrens Hospital Los Angeles and Emergency Medicine Attending Physician in the Pediatric Emergency Department at Los Angeles County-USC Medical Center.

In 2008, Dr. Goldstein developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Since then she has been evaluating both adult and pediatric patients for use of medical cannabis. Dr. Goldstein has given numerous lectures to many patient support programs, including the Cancer Support Community, Southern California Prosthetics, and Pediatric Epilepsy. She has also lectured at CannaMed 2016 at Harvard University, United in Compassion Medical Cannabis Symposium in Sydney, Australia,  Patients Out of Time 2015, and United Patients Group Conference 2016.

She is currently the Medical Director of Canna-Centers, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions.  She is a Medical Consultant to  She is a Member of the International Association of Cannabis as Medicine, the International Cannabinoid Research Society, and the Society of Cannabis Clinicians.

Dr. Goldstein held a webinar for Medcan and spoke about the latest studies to show how and why cannabis can be of benefit, she spoke about the benefits of whole plant over isolates and how they dose and treat epilepsy in California. She also spoke of the problems they have had in accessing cannabis and something we can learn from and help guide industry moving forward here in the UK.

It was a really informative discussion and many families took a huge amount away from it.




Company Interest Charity 13392814